Tetrabenazine (Nitoman/Xenazine)

Tetrabenazine (Trade name: Nitoman/Xenazine) is a vesicular monoamine transporter 2 (VMAT2) inhibitor used in the treatment of Huntington's Disease and tardive dyskinesia.

Pharmacokinetics of Tetrabenazine

Tetrabenazine: Cytochrome P450 Metabolism

Substrate of (Metabolized by)
Induces
Inhibits

Dosing for Tetrabenazine

Starting
Titration
Maximum
Taper
  • Tetrabenazine comes in